A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare efficacy and safety of Exubera® vs Lantus® in patients with type 2 diabetes mellitus.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Diabetes Mellitus, Type 2 on oral agents

• Age > 30 years

Exclusion Criteria:

• Severe Asthma, severe Chronic Obstructive Pulmonary Disease

• Smoking